IPHA Guidance on Direct HealthCare Professional Communication (DHPC)

The Irish Pharmaceutical Healthcare Association (IPHA) has produced a Guidance on Direct Healthcare Professional Communication (DHPC).

Read more

IPHA welcomes decision to reimburse Cystic Fibrosis medicines

The Irish Pharmaceutical Healthcare Association (IPHA) has welcomed the decision by the HSE to reimburse new Cystic Fibrosis medicines as evidence of a policy commitment to new patients getting access to new medicines.

Read more

Big jump in users of medicine information website

A total of 4,661,057 visitors were recorded accessing the medicine information website, Medicines.ie.

Read more

IPHA Submission on HIQAs Consultation on smoking cessation

The Irish Pharmaceutical Healthcare Association (IPHA) represents the international research-based companies who are responsible for developing, manufacturing and bringing innovative medicines to the Irish market. We support the need for evidence based decision making, welcome the principle of a reviewof smoking cessation methods and applaud the government’s efforts to prevent and reduce the use of tobacco. 

Read more

IPHA refutes fake claims on Pricing Agreement

The Irish Pharmaceutical Healthcare Association (IPHA), which represents the research based pharmaceutical industry in Ireland, has strongly refuted claims by the Healthcare Enterprise Alliance (HEA) that the new pricing Agreement negotiated with the State last summer is not bringing value.

Read more